ROYAL BANK OF CANADA

Bank

Position in RANI — Rani Therapeutics Holdings, Inc.

CIK 1000275 TORONTO, A6

Position in RANI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$94

-$3 QoQ

Shares Held

124

-6.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 67 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. RANI ranks #397 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$94	124	-6.1%	Shares	Sole	2026-08-14
2026-03-31	$97	132	+3.9%	Shares	Sole	2026-05-15
2025-12-31	$171	127	+225.6%	Shares	Sole	2026-02-17
2025-09-30	$19	39	+25.8%	Shares	Sole	2025-11-14
2025-06-30	$15	31	+158.3%	Shares	Sole	2025-11-21
2024-06-30	$45	12	0.0%	Shares	Defined	2024-11-06
2024-03-31	$37	12	0.0%	Shares	Defined	2024-11-05
2023-12-31	$39	12	-72.1%	Shares	Defined	2024-02-14
2023-09-30	$93	43	-50.6%	Shares	Defined	2023-11-14
2023-06-30	$358	87	0.0%	Shares	Defined	2023-08-14
2023-03-31	$448	87	0.0%	Shares	Defined	2023-05-15
2022-12-31	$513	87	-2.2%	Shares	Defined	2023-02-14
2022-09-30	$852	89	+229.6%	Shares	Defined	2022-11-14
2022-06-30	$278	27	0.0%	Shares	Defined	2022-08-15
2022-03-31	$364	27	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.